The failure of STIM1/STIM2-deficient T cells to control tumour growth in DKO mice could be due to several mechanisms including impaired priming and expansion of tumour antigen-specific CD8+ T cells, lack of migration into tumours, abolished cytotoxic function or a combination of the above. The gene discussed is STIM2; the disease is neoplasm.